AegirBio AB (SUBGEN) Stock Statistics & Valuation Metrics

AegirBio AB has a market cap or net worth of kr89.16M. The enterprise value is kr436.32.

AegirBio AB has 1,482,451,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

AegirBio AB’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -23.04%.

The current PE Ratio of AegirBio AB is ―. AegirBio AB’s PEG ratio is 0.02.

In the last 12 months, AegirBio AB had revenue of 204.39M and earned -88.88M in profits. Earnings per share was -0.41.

In the last 12 months, operating cash flow was -17.90M and capital expenditures -24.30M, giving a free cash flow of -23.62M billion.

AegirBio AB pays an annual dividend of ―, resulting in a dividend yield of ―

AegirBio AB upcoming earnings date is Aug 20, 2026, TBA (Confirmed).

AegirBio AB as a current ratio of 0.75, with Debt / Equity ratio of ―

In the past 12 months, AegirBio AB has paid -1.12M in taxes.

AegirBio AB EV to EBITDA ratio is -0.80, with an EV/FCF ratio of -4.07.

AegirBio AB has kr18.74M in cash and marketable securities with kr285.65M in debt, giving a net cash position of -kr83.67M billion.

Gross margin is ―, with operating margin of -63.22%, and net profit margin of -43.48%.

The average price target for AegirBio AB is ―, which is 11.43% higher than the current price. The consensus rating is ―